search
Back to results

Evaluating Home Testing Devices for the Management of Glaucoma

Primary Purpose

Glaucoma, Open-Angle

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Standard Automatic Perimetry Humphrey Field Analyzer
visuALL H
iCare Home Tonometer
Spectralis Optical coherence tomography (OCT)
Sponsored by
Wills Eye
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Glaucoma, Open-Angle focused on measuring Open Angle Glaucoma, Perimetery, Tonometry, Eye Pressure, Visual Field, Home Test

Eligibility Criteria

20 Years - 80 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Age 20-80 years
  2. Mild and Moderate Open Angle Glaucoma (OAG)
  3. Refraction under 12.00 diopter of spherical refractive error and astigmatism of less than 2.5 diopter.

Exclusion Criteria:

  1. Spherical refraction outside > ± 12.00 D and cylinder correction > +2.5 D.
  2. Visual acuity worse than 20/50 either eye
  3. Cataract surgery with or without Minimally Invasive Glaucoma Surgery (MIGS) less than 90 days prior to enrollment
  4. Filtering surgeries less than 6 months prior to enrollment
  5. Intraocular surgery other than:

    1. Non-complicated MIGS more than 90 days prior to enrollment;
    2. Cataract or refractive surgery performed more than 90 days before enrollment and without posterior capsule opacification
    3. Other glaucoma surgery more than 6 months prior to enrollment.
  6. History of systemic or ocular condition (other than glaucoma or mild to moderate cataract) known to affect visual function.
  7. History of medication known to affect visual function or influence patient reaction time
  8. Inability to use device after remote training session
  9. Subjects unwilling and/or unable to participate

Sites / Locations

  • Wills Eye HospitalRecruiting

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Moderate Glaucoma

Arm Description

Subjects between ages 20-80 years with a diagnosis of mild and moderate Open Angle Glaucoma in at least one eye with 20/50 vision or better will be included in this study. All subjects will have the Olleyes Perimeter measure their own visual acuity and field once a week during a 2 year period and iCare home to measure their eye pressure 3 times a day for 7 days every 3 months during a 2 year period. All patient will have their routine glaucoma assessment with the standard 24-2 Automatic Perimetry Humphrey Field Analyzer at baseline and every 6 months during a 2 year period; and Spectralis Optical Coherence Tomography thickness of peripapillary RNFL and macular ganglion cell at baseline and yearly during a 2 year period.

Outcomes

Primary Outcome Measures

Change in Visual Field Mean Deviation with VisuALL
The visual field measures sensitivity of the retina to light at several locations in the peripheral vision. The difference of mean of these measurements compared to a normal database is presented in negative or positive values called mean deviation. Visual field mean deviation (MD) (light measurement in decibels in multiple spots across the central and peripheral retina known as entire visual field) will be captured by VisuALL per eye once a week during a 2 year period at participant's home.
Change in Intraocular Pressure with iCare
Intraocular pressure, measured in millimeters of mercury (mmHG), will be measured by patients using a device called iCare Home Tonometer, specifically designed for patients to measure their eye pressures at home. They will measure eye pressure of each eye 3 times a day for 7 days every 3 months during a 2 year period at participant's home.

Secondary Outcome Measures

Change in Visual Field Mean Deviation with Humphrey Field Analyzer
The visual field measures sensitivity of the retina to light at several locations in the peripheral vision. The difference of mean of these measurements compared to a normal database is presented in negative or positive values called mean deviation. Visual field mean deviation (MD) (light measurement in decibels in multiple spots across the central and peripheral retina known as entire visual field) will be measured in the office by Humphrey perimeter 24-2 SITA standard per 3 times at baseline and then every 6 months during a 2 year period..

Full Information

First Posted
March 25, 2022
Last Updated
May 1, 2023
Sponsor
Wills Eye
search

1. Study Identification

Unique Protocol Identification Number
NCT05325996
Brief Title
Evaluating Home Testing Devices for the Management of Glaucoma
Official Title
Evaluating Effectiveness of Home Testing Devises for Assisting in Management of Glaucoma Outside a Clinical Setting During a 2 Year Period.
Study Type
Interventional

2. Study Status

Record Verification Date
May 2023
Overall Recruitment Status
Recruiting
Study Start Date
April 15, 2022 (Actual)
Primary Completion Date
August 31, 2025 (Anticipated)
Study Completion Date
August 31, 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Wills Eye

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Data Monitoring Committee
No

5. Study Description

Brief Summary
With the advancement in technology we have the opportunity of performing the glaucoma testing at home to monitor the disease. The purpose of this study is evaluating the feasibility and patient acceptance of home testing with head mounted perimetry; detection of progression with head mounted perimetry vs office based perimetry; and monitoring the eye pressure measured by patients at home using a portable tonometer.
Detailed Description
Standard Automatic Perimetry (SAP) is the gold standard test for evaluation of diseases of the visual pathway like glaucoma. Its main goal is to measure differential light sensitivity at several locations in the field of vision. Several devices have been developed since the advent of the Octopus Perimeter and the Humphrey Field Analyzer (HFA) is now the most commonly used machine for checking the visual field. These devices have a number of disadvantages including being stressful for debilitated, ill, or elderly patients to keep their heads still in the perimeter bowl during the test. Recently, several methods have been introduced for checking the visual field using laptops or iPads. These modalities bring portability but lack fixation methods, environmental control, hardware standardization, and lack the ability of checking the visual acuity. These deficiencies may limit their wide usage. VisuALL is a Head Mounted perimeter that connects to its application on the cell phone or tablet via Bluetooth. In addition to being a portable perimeter and checking visual acuity, it has the ability of monitoring fixation with an accuracy of 1 degree. The measured visual field will be saved on a cloud space and available to the physician and patient. It has been shown that the more frequent visual tests we perform, the earlier we would be able to detect visual field progression. Currently, the visual field test is performed on patients in an ophthalmology clinic with a technician present during the test. The VisuALL has a demo video to provide education to the patient on the simple and user-friendly process of visual field testing. Tonometry is the measurement of eye pressure. iCare Home Tonometer measurements have been shown to be highly correlated to Goldmann Tonometer measurements which are performed in the ophthalmic office. Multiple studies have highlighted the shortcomings of relatively infrequent in office tonometry. Recent studies have suggested that peak out of office eye pressures are often higher than in office pressures and the iCare Home Tonometer is one option to assess eye pressure outside of the office. Home monitoring of glaucoma may present opportunities to reduce the burdens of office visits while increasing the monitoring of the visual field and eye pressure. This study is intended to assess the feasibility and utility of home based perimetry and tonometry in the management of glaucoma.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Glaucoma, Open-Angle
Keywords
Open Angle Glaucoma, Perimetery, Tonometry, Eye Pressure, Visual Field, Home Test

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
50 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Moderate Glaucoma
Arm Type
Experimental
Arm Description
Subjects between ages 20-80 years with a diagnosis of mild and moderate Open Angle Glaucoma in at least one eye with 20/50 vision or better will be included in this study. All subjects will have the Olleyes Perimeter measure their own visual acuity and field once a week during a 2 year period and iCare home to measure their eye pressure 3 times a day for 7 days every 3 months during a 2 year period. All patient will have their routine glaucoma assessment with the standard 24-2 Automatic Perimetry Humphrey Field Analyzer at baseline and every 6 months during a 2 year period; and Spectralis Optical Coherence Tomography thickness of peripapillary RNFL and macular ganglion cell at baseline and yearly during a 2 year period.
Intervention Type
Diagnostic Test
Intervention Name(s)
Standard Automatic Perimetry Humphrey Field Analyzer
Other Intervention Name(s)
SAP HFA
Intervention Description
Standard Automatic Perimetry (SAP) using the Swedish Interactive Threshold Algorithm (SITA) Standard Strategy measures the visual field in an ophthalmic setting.
Intervention Type
Diagnostic Test
Intervention Name(s)
visuALL H
Intervention Description
visuALL H a new portable perimeter measuring the visual field and acuity in a non ophthalmic setting.
Intervention Type
Diagnostic Test
Intervention Name(s)
iCare Home Tonometer
Intervention Description
iCare HOME tonometer is a device developed for patients/subjects to measure their eye pressure at home.
Intervention Type
Diagnostic Test
Intervention Name(s)
Spectralis Optical coherence tomography (OCT)
Intervention Description
Optical coherence tomography (OCT) is a computerized picture measuring the thickness of the inner layer of the retina that makes the optic nerve.
Primary Outcome Measure Information:
Title
Change in Visual Field Mean Deviation with VisuALL
Description
The visual field measures sensitivity of the retina to light at several locations in the peripheral vision. The difference of mean of these measurements compared to a normal database is presented in negative or positive values called mean deviation. Visual field mean deviation (MD) (light measurement in decibels in multiple spots across the central and peripheral retina known as entire visual field) will be captured by VisuALL per eye once a week during a 2 year period at participant's home.
Time Frame
12 minutes each week for 104 weeks
Title
Change in Intraocular Pressure with iCare
Description
Intraocular pressure, measured in millimeters of mercury (mmHG), will be measured by patients using a device called iCare Home Tonometer, specifically designed for patients to measure their eye pressures at home. They will measure eye pressure of each eye 3 times a day for 7 days every 3 months during a 2 year period at participant's home.
Time Frame
15 minutes daily over 1 week, 8 times for 2 years
Secondary Outcome Measure Information:
Title
Change in Visual Field Mean Deviation with Humphrey Field Analyzer
Description
The visual field measures sensitivity of the retina to light at several locations in the peripheral vision. The difference of mean of these measurements compared to a normal database is presented in negative or positive values called mean deviation. Visual field mean deviation (MD) (light measurement in decibels in multiple spots across the central and peripheral retina known as entire visual field) will be measured in the office by Humphrey perimeter 24-2 SITA standard per 3 times at baseline and then every 6 months during a 2 year period..
Time Frame
2 hours, 5 times for 2 years
Other Pre-specified Outcome Measures:
Title
Change in Retinal Nerve Fiber Layer (RNFL) Thickness
Description
Retinal Nerve Fiber Layer (RNFL) Thickness in microns will be obtained by a computerized picture without touching the eye with Spectralis (Zeiss) Optical Coherence Tomography (OCT) at baseline and then yearly during a 2 year period.
Time Frame
10 minutes, 3 times for 2 years

10. Eligibility

Sex
All
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age 20-80 years Mild and Moderate Open Angle Glaucoma (OAG) Refraction under 12.00 diopter of spherical refractive error and astigmatism of less than 2.5 diopter. Exclusion Criteria: Spherical refraction outside > ± 12.00 D and cylinder correction > +2.5 D. Visual acuity worse than 20/50 either eye Cataract surgery with or without Minimally Invasive Glaucoma Surgery (MIGS) less than 90 days prior to enrollment Filtering surgeries less than 6 months prior to enrollment Intraocular surgery other than: Non-complicated MIGS more than 90 days prior to enrollment; Cataract or refractive surgery performed more than 90 days before enrollment and without posterior capsule opacification Other glaucoma surgery more than 6 months prior to enrollment. History of systemic or ocular condition (other than glaucoma or mild to moderate cataract) known to affect visual function. History of medication known to affect visual function or influence patient reaction time Inability to use device after remote training session Subjects unwilling and/or unable to participate
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Jeanne L Molineaux, COA
Phone
215-825-4713
Email
jmolineaux@willseye.org
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
M. Reza Razeghinejad, MD
Organizational Affiliation
Wills Eye Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Wills Eye Hospital
City
Philadelphia
State/Province
Pennsylvania
ZIP/Postal Code
19107
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jeanne L Molineaux, COA
Phone
215-825-4713
Email
jmolineaux@willseye.org
First Name & Middle Initial & Last Name & Degree
L. Jay Katz, MD
First Name & Middle Initial & Last Name & Degree
Jonathan S Myers, MD
First Name & Middle Initial & Last Name & Degree
Daniel Lee, MD
First Name & Middle Initial & Last Name & Degree
Natasha N Kolomeyer, MD
First Name & Middle Initial & Last Name & Degree
Lauren E Hock, MD
First Name & Middle Initial & Last Name & Degree
Marlene R Moster, MD

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Evaluating Home Testing Devices for the Management of Glaucoma

We'll reach out to this number within 24 hrs